Arlington Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.34M | Buy |
+61,002
| New | +$2.34M | 0.86% | 55 |
|
|
2023
Q3 | – | Sell |
-320
| Closed | -$11.4K | – | 503 |
|
|
2023
Q2 | $11.4K | Buy |
+320
| New | +$11.4K | ﹤0.01% | 454 |
|
|
2022
Q1 | – | Sell |
-416
| Closed | -$23K | – | 532 |
|
|
2021
Q4 | $23K | Buy |
+416
| New | +$23K | 0.01% | 354 |
|
|
2020
Q2 | – | Sell |
-98
| Closed | -$5K | – | 217 |
|
|
2020
Q1 | $5K | Sell |
98
-162
| -62% | -$8.27K | ﹤0.01% | 188 |
|
|
2019
Q4 | $15K | Hold |
260
| – | – | 0.01% | 179 |
|
|
2019
Q3 | $14K | Hold |
260
| – | – | 0.01% | 147 |
|
|
2019
Q2 | $13K | Hold |
260
| – | – | 0.01% | 192 |
|
|
2019
Q1 | $14K | Hold |
260
| – | – | 0.01% | 162 |
|
|
2018
Q4 | $12K | Buy |
+260
| New | +$12K | 0.01% | 166 |
|